Hikma Pharmaceuticals Plc

Hikma Enters the Moroccan Market Through the Acquisition of 63.9% of Promopharm and Will Launch a Mandatory Tender Offer for the Remaining 36.1%

Older News

LONDON, October 3, 2011 - Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) ("Hikma"), the fast growing multinational pharmaceutical group, today announces that it has acquired 63.9% of Socit de Promotion Pharmaceutique du Maghreb S.A.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy